Midbrain presynaptic dopamine tone predicts sustained and transient neural response to emotional salience in humans: fMRI, MEG and FDOPA PET

Molecular Psychiatry

Volumn 18, Issue 1, 2013, Pages 4-6

  Jabbi, M ^a,b   Nash, T ^a,b   Kohn, P ^a,b   Ianni, A ^a,b   Rubinstein, D ^a,b,c   Holroyd, T ^c   Carver, F W ^c   Masdeu, J C ^a,b   Shane Kippenhan, J ^a,b   Robinson, S E ^c   Coppola, R ^b,c   Berman, K F ^a,b  

^a Section on Integrative Neuroimaging   (United States)

^b Genes   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; DOPAMINE;

ASSOCIATION; COGNITION; DOPAMINERGIC TRANSMISSION; EMOTION; FACIAL EXPRESSION; FEAR; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GAMMA RADIATION; HUMAN; HUMAN EXPERIMENT; LETTER; MAGNETOENCEPHALOGRAPHY; MAGNETOMETRY; MALE; MESENCEPHALON; NEUROIMAGING; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; VIDEORECORDING;

ADULT; BRAIN MAPPING; DIHYDROXYPHENYLALANINE; DOPAMINE; EMOTIONS; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETOENCEPHALOGRAPHY; MALE; MESENCEPHALON; OXYGEN; PHOTIC STIMULATION; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PRESYNAPTIC TERMINALS;

EID: 84871299789     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2012.12     Document Type: Letter

References (10)

1. Camerer C, Loewenstein G. In: Camerer C, Loewenstein G, Rabin M (eds). Advance in Behavioral Economics. Princeton University Press: Princeton, 2004, pp 3-51.
2. Abdellaoui M, Bleichrodt H, Paraschiv C. Manage Sci 2007; 53: 1659-1674.
3. Blair K, Morton J, Leonardand A, Blair RJR. Pers Individ Dif 2006; 41: 155-165.
4. Van Holst RJ, Van Den Brink W, Veltman DJ, Goudriaan AE. Neurosci Biobehav Rev 2010; 34: 87-107.
5. Tom S, Fox C, Trepel C, Poldrack R. Science 2007; 315: 515-518.
6. De Martino B, Camerer CF, Adolphs R. Proc Natl Acad Sci USA 2010; 107: 3788-3792.
7. Rogers RD, Lancaster M, Wakeley J, Bhagwagar Z. Psychopharmacology 2004; 172: 157-164.
8. Sokol-Hessner P, Hsu M, Curley NG, Delgado MR, Camerer CF, Phelps EA.Proc Natl Acad Sci USA 2009; 106: 5035-5040.
9. Berridge CW. Brain Res Rev 2008; 58: 1-17.
10. De Martino B, Strange BA, Dolan RJ. Psychopharmacology 2008; 197: 127-136.